bones7rr
Sensitive Young Man
TB-500
- Category / Status: Unapproved Peptide
- Direct Bone Impact: Low / Indirect — supports blood vessel growth; primarily soft-tissue focused
- Administration: Subcutaneous injection, 1–2× per week
- Typical Dosing Range: 2.0–5.0 mg/week
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $40–$90
SR9009
- Category / Status: Unapproved REV-ERB Agonist
- Direct Bone Impact: Moderate / Protective — inhibits osteoclasts to reduce bone loss
- Administration: Oral / Sublingual, 3–4× daily
- Typical Dosing Range: 10–30 mg/day
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $50–$80
BPC-157
- Category / Status: Unapproved Peptide
- Direct Bone Impact: High / Repair — claimed to accelerate fracture calluses and tendon-to-bone binding
- Administration: Subcutaneous or oral, 1–2× daily
- Typical Dosing Range: 250–500 mcg/day
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $45–$80
Tymlos (abaloparatide)
- Category / Status: FDA-Approved Drug
- Direct Bone Impact: Extremely High / Anabolic — directly stimulates osteoblast-mediated bone formation
- Administration: Subcutaneous injection, once daily
- Typical Dosing Range: 80 mcg/day
- Est. Monthly Cost (Insurance/Generic): $0–$50 (copay card)
- Est. Monthly Cost (Cash): ~$2,200
HGH
- Category / Status: Prescription / Underground
- Direct Bone Impact: High / Density — may increase long-term cortical bone thickness
- Administration: Subcutaneous injection, once daily at night
- Typical Dosing Range: 1.0–3.0 IU/day
- Est. Monthly Cost (Insurance/Generic): ~$150 (generic)
- Est. Monthly Cost (Cash/Pharma Grade): ~$800–$1,200+
Trenbolone
- Category / Status: Anabolic Steroid
- Direct Bone Impact: Paradoxical / Negative — can suppress estrogen and potentially harm bone health without adequate testosterone/estrogen
- Administration: Intramuscular injection, 2–3× per week
- Typical Dosing Range: 100–300 mg/week
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $30–$75
Testosterone
- Category / Status: FDA-Approved Prescription Hormone
- Direct Bone Impact: Moderate / Supportive — testosterone contributes to maintaining bone mineral density; some effects occur through conversion to estradiol
- Administration: Injection, gel, patch, or other prescribed formulations
- Typical Dosing Range: Individualized by a clinician based on indication and blood levels
- Est. Monthly Cost (Insurance/Generic): Varies by formulation and insurance
- Est. Monthly Cost (Cash / Generic): Varies by formulation and pharmacy
All credits to bones7rr (cenuxx.org on tiktok)
- Category / Status: Unapproved Peptide
- Direct Bone Impact: Low / Indirect — supports blood vessel growth; primarily soft-tissue focused
- Administration: Subcutaneous injection, 1–2× per week
- Typical Dosing Range: 2.0–5.0 mg/week
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $40–$90
SR9009
- Category / Status: Unapproved REV-ERB Agonist
- Direct Bone Impact: Moderate / Protective — inhibits osteoclasts to reduce bone loss
- Administration: Oral / Sublingual, 3–4× daily
- Typical Dosing Range: 10–30 mg/day
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $50–$80
BPC-157
- Category / Status: Unapproved Peptide
- Direct Bone Impact: High / Repair — claimed to accelerate fracture calluses and tendon-to-bone binding
- Administration: Subcutaneous or oral, 1–2× daily
- Typical Dosing Range: 250–500 mcg/day
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $45–$80
Tymlos (abaloparatide)
- Category / Status: FDA-Approved Drug
- Direct Bone Impact: Extremely High / Anabolic — directly stimulates osteoblast-mediated bone formation
- Administration: Subcutaneous injection, once daily
- Typical Dosing Range: 80 mcg/day
- Est. Monthly Cost (Insurance/Generic): $0–$50 (copay card)
- Est. Monthly Cost (Cash): ~$2,200
HGH
- Category / Status: Prescription / Underground
- Direct Bone Impact: High / Density — may increase long-term cortical bone thickness
- Administration: Subcutaneous injection, once daily at night
- Typical Dosing Range: 1.0–3.0 IU/day
- Est. Monthly Cost (Insurance/Generic): ~$150 (generic)
- Est. Monthly Cost (Cash/Pharma Grade): ~$800–$1,200+
Trenbolone
- Category / Status: Anabolic Steroid
- Direct Bone Impact: Paradoxical / Negative — can suppress estrogen and potentially harm bone health without adequate testosterone/estrogen
- Administration: Intramuscular injection, 2–3× per week
- Typical Dosing Range: 100–300 mg/week
- Est. Monthly Cost (Insurance/Generic): N/A
- Est. Monthly Cost (Cash/Underground): $30–$75
Testosterone
- Category / Status: FDA-Approved Prescription Hormone
- Direct Bone Impact: Moderate / Supportive — testosterone contributes to maintaining bone mineral density; some effects occur through conversion to estradiol
- Administration: Injection, gel, patch, or other prescribed formulations
- Typical Dosing Range: Individualized by a clinician based on indication and blood levels
- Est. Monthly Cost (Insurance/Generic): Varies by formulation and insurance
- Est. Monthly Cost (Cash / Generic): Varies by formulation and pharmacy
All credits to bones7rr (cenuxx.org on tiktok)
